Prednisone chronotherapy

Clinical and Experimental Rheumatology

Volumn 29, Issue 5 SUPPL. 68, 2011, Pages

  Spies, C M ^a   Cutolo, M ^b   Straub, R H ^c   Burmester, G R ^a   Buttgereit, F ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Chronotherapeutics; Chronotherapy; Glucocorticoid; Modified release prednisone; Morning stiffness; MR prednisone; Prednisone chronotherapy; Rheumatoid arthritis; Therapy; Timing

Indexed keywords

GLUCOCORTICOID; HYDROCORTISONE; INTERLEUKIN 6; METHOTREXATE; OPIATE; PREDNISOLONE; PREDNISONE;

ANKYLOSING SPONDYLITIS; ANTIINFLAMMATORY ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BEDTIME DOSAGE; CHRONOBIOLOGY; CHRONOTHERAPY; CIRCADIAN RHYTHM; CLINICAL PRACTICE; CONGENITAL ADRENAL HYPERPLASIA; DRUG EFFICACY; DRUG EXPOSURE; DRUG HALF LIFE; DRUG RELEASE; DRUG SAFETY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; JOINT STIFFNESS; LOW DRUG DOSE; MORNING DOSAGE; PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS;

ARTHRITIS, RHEUMATOID; DRUG CHRONOTHERAPY; GLUCOCORTICOIDS; HUMANS; PREDNISONE;

EID: 81155144644     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. FARDET L, PETERSEN I, NAZARETH I: Prevalence of long-term oral glucocorticoid prescriptions in UK over the past 20 years. Rheumatology (Oxford) 2011; [Epub ahead of print].
2. HOES JN, JACOBS JW, BIJLSMA JW: Glucocorticoids are forever? Rheumatology (Oxford) 2011; [Epub ahead of print].
3. BUTTGEREIT F, BURMESTER GR, STRAUB RH, SEIBEL MJ, ZHOU H: Exogenous and endogenous glucocorticoids in rheumatic diseases. Arthritis Rheum 2011; 63: 1-9.
4. KIRWAN JR, BIJLSMA JW, BOERS M, SHEA BJ: Effects of glucocorticoids on radiological progression in rheumatoid arthritis. Cochrane Database Syst Rev 2007: CD006356.
5. DA SILVA JA, JACOBS JW, KIRWAN JR et al.: Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis 2006; 65: 285-93. (Pubitemid 43268214)
6. HOES JN, JACOBS JW, BOERS M et al.: EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 2007; 66: 1560-7. (Pubitemid 350205441)
7. VAN DER GOES MC, JACOBS JW, BOERS M et al.: Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice. Ann Rheum Dis 2010; 69: 1913-9.
8. HUSCHER D, THIELE K, GROMNICAIHLE E et al.: Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis 2009; 68: 1119-24.
9. SCHACKE H, DOCKE WD, ASADULLAH K: Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 2002; 96: 23-43. (Pubitemid 35346616)
10. BUTTGEREIT F, DOERING G, SCHAEFFLER A et al.: Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial. Lancet 2008; 371: 205-14.
11. LEMMER B: Chronobiology, drug-delivery, and chronotherapeutics. Adv Drug Deliv Rev 2007; 59: 825-7. (Pubitemid 47531901)
12. LEMMER B: Discoveries of rhythms in human biological functions: a historical review. Chronobiol Int 2009; 26: 1019-68.
13. SMOLENSKY MH, PEPPAS NA: Chronobiology, drug delivery, and chronotherapeutics. Adv Drug Deliv Rev 2007; 59: 828-51. (Pubitemid 47542291)
14. SMOLENSKY MH, PEPPAS NA: Chronobiology, drug delivery, and chronotherapeutics. Adv Drug Deliv Rev 2007; 59: 823-4.
15. SEWLALL S, PILLAY V, DANCKWERTS MP, CHOONARA YE, NDESENDO VM, DUTOIT LC: A timely review of state-of-the-art chronopharmaceuticals synchronized with biological rhythms. Curr Drug Deliv 2010; 7: 370-88.
16. HARTER JG, REDDY WJ, THORN GW: Studies on an intermittent corticosteroid dosage regimen. N Engl J Med 1963; 269: 591-6.
17. SMOLENSKY MH, LEMMER B, REINBERG AE: Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma. Adv Drug Deliv Rev 2007; 59: 852-82. (Pubitemid 47542292)
18. DI RAIMONDO VC, FORSHAM PH: Some clinical implications of the spontaneous diurnal variation in adrenal cortical secretory activity. Am J Med 1956; 21: 321-3.
19. ANGELI A: Orcadian ACTH-adrenal rhythm in man. Chronobiologia 1974; 1 (Suppl. 1): 253-70.
20. CERESA F, ANGELI A, BOCCUZZI G, MOLINO G: Once-a-day neurally stimulated and basal ACTH secretion phases in man and their response to corticoid inhibition. J Clin Endocrinol Metab 1969; 29: 1074-82.
21. GRANT SD, FORSHAM PH, DIRAIMONDO VC: Suppression of 17- hydroxycorticosteroids in plasma and urine by single and divided doses of triamcinolone. N Engl J Med 1965; 273: 1115-8.
22. NICHOLS T, NUGENT CA, TYLER FH: Diurnal Variation in Suppression of Adrenal Function by Glucocorticoids. J Clin Endocrinol Metab 1965;25:343-9.
23. KLINEFELTER HF, WINKENWERDER WL, BLEDSOE T: Single daily dose prednisone therapy. JAMA 1979; 241: 2721-3. (Pubitemid 9226248)
24. DE SILVA M, BINDER A, HAZLEMAN BL: The timing of prednisolone dosage and its effect on morning stiffness in rheumatoid arthritis. Ann Rheum Dis 1984; 43: 790-3. (Pubitemid 15190182)
25. DEANDRADE JR, MCCORMICK JN, HILL AG: Small doses of prednisolone in the management of rheumatoid arthritis. Ann Rheum Dis 1964; 23: 158-62.
26. NUGENT CA, WARD J, MACDIARMID WD, McCALL JC, BAUKOL J, TYLER FH: Glucocorticoid toxicity: single contrasted with divided daily doses of prednisolone. J Chronic Dis 1965; 18: 323-32.
27. KOWANKO IC, POWNALL R, KNAPP MS, SWANNELL AJ, MAHONEY PG: Time of day of prednisolone administration in rheumatoid arthritis. Ann Rheum Dis 1982; 41: 447-52. (Pubitemid 12035487)
28. STRAUB RH, CUTOLO M: Orcadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. Arthritis Rheum 2007; 56: 399-408.
29. BELLAMY N, SOTHERN RB, CAMPBELL J, BUCHANAN WW: Orcadian rhythm in pain, stiffness, and manual dexterity in rheumatoid arthritis: relation between discomfort and disability. Ann Rheum Dis 1991; 50: 243-8.
30. HARKNESS JA, RICHTER MB, PANAYI GS et al.: Orcadian variation in disease activity in rheumatoid arthritis. Br Med J (Clin Res Ed) 1982;284:551-4. (Pubitemid 12173542)
31. INGPEN ML: The quantitative measurement of joint changes in rheumatoid arthritis. Ann Phys Med 1968; 9: 322-7.
32. KOWANKO IC, POWNALL R, KNAPP MS, SWANNELL AJ, MAHONEY PG: Orcadian variations in the signs and symptoms of rheumatoid arthritis and in the therapeutic effectiveness of flurbiprofen at different times of day. Br J Clin Pharmacol 1981; 11: 477-84. (Pubitemid 11150188)
33. OLSEN NJ, BROOKS RH, FURST D: Variability of immunologic and clinical features in patients with rheumatoid arthritis studied over 24 hours. J Rheumatol 1993; 20: 940-3. (Pubitemid 23203230)
34. STONE AA, BRODERICK JE, PORTER LS, KAELL AT: The experience of rheumatoid arthritis pain and fatigue: examining momentary reports and correlates over one week. Arthritis Care Res 1997; 10: 185-93. (Pubitemid 27279751)
35. ARVIDSON NG, GUDBJORNSSON B, ELFMAN L, RYDEN AC, TOTTERMAN TH, HALLGREN R: Orcadian rhythm of serum interleukin-6 in rheumatoid arthritis. Ann Rheum Dis 1994;53:521-4. (Pubitemid 24256982)
36. CROFFORD U, KALOGERAS KT, MASTORAKOS G et al.: Orcadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J Clin Endocrinol Metab 1997; 82: 1279-83. (Pubitemid 27166676)
37. PERRY MG, KIRWAN JR, JESSOP DS, HUNT LP: Overnight variations in Cortisol, interleukin 6, tumour necrosis factor alpha and other cytokines in people with rheumatoid arthritis. Ann Rheum Dis 2009; 68: 63-8.
38. DAYER JM, CHOY E: Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor. Rheumatology (Oxford) 2010; 49: 15-24.
39. BUTTGEREIT F, STRAUB RH, WEHLING M, BURMESTER GR: Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action. Arthritis Rheum 2004; 50: 3408-17. (Pubitemid 39488664)
40. WESTHOFF G, BUTTGEREIT F, GROMNICAIHLE E, ZINK A: Morning stiffness and its influence on early retirement in patients with recent onset rheumatoid arthritis. Rheumatology (Oxford) 2008; 47: 980-4. (Pubitemid 351865919)
41. SPIES CM, CUTOLO M, STRAUB RH, BURMESTER GR, BUTTGEREIT F: More night than day - circadian rhythms in polymyalgia rheumatica and ankylosing spondylitis. J Rheumatol 2010; 37: 894-9.
42. KEES MG, PONGRATZ G, KEES F, SCHOLMERICH J, STRAUB RH: Via beta-adrenoceptors, stimulation of extrasplenic sympathetic nerve fibers inhibits lipopolysaccharide-induced TNF secretion in perfused rat spleen. J Neuroimmunol 2003; 145: 77-85. (Pubitemid 37492878)
43. PETROVSKY N, MCNAIR P, HARRISON LC: Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma Cortisol and therapeutic implications. Cytokine 1998; 10: 307-12. (Pubitemid 28227075)
44. ARVIDSON NG, GUDBJORNSSON B, LARSSON A, HALLGREN R: The timing of glucocorticoid administration in rheumatoid arthritis. Ann Rheum Dis 1997; 56: 27-31. (Pubitemid 27060569)
45. BUTTGEREIT F, DOERING G, SCHAEFFLER A et al.: Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis. Ann Rheum Dis 2010; 69: 1275-80.
46. STRAUB RH, PAIMELA L, PELTOMAA R, SCHOLMERICH J, LEIRISALOREPO M: Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis. Arthritis Rheum 2002; 46: 654-62. (Pubitemid 34214248)
47. STRAUB RH, PONGRATZ G, CUTOLO M et al.: Increased Cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritis. Arthritis Rheum 2008; 58: 976-84. (Pubitemid 351563998)
48. ALTEN R, DORING G, CUTOLO M et al.: Hypothalamus-pituitary-adrenal axis function in patients with rheumatoid arthritis treated with night time-release prednisone. J Rheumatol 2010; 37: 2025-31.
49. BURIOKA N, FUKUOKA Y, KOYANAGI S et al.: Asthma: Chronopharmacotherapy and the molecular clock. Adv Drug Deliv Rev 2010;62:946-55.
50. REINBERG A, HALBERG F, FALLIERS CJ: Orcadian timing of methylprednisolone effects in asthmatic boys. Chronobiologia 1974; 1:333-47.
51. GLASS-MARMOR L, PAPERNA T, GALBOIZ Y, MILLER A: Immunomodulation by chronobiologically-based glucocorticoids treatment for multiple sclerosis relapses. J Neuroimmunol 2009; 210: 124-7.
52. VERMA S, VANRYZIN C, SINAII N et al.: A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 2010; 72:441-7.
53. CUTOLO M, MASI AT: Orcadian rhythms and arthritis. Rheum Dis Clin North Am 2005; 31: 115-29, ix-x.
54. CUTOLO M, STRAUB RH, BUTTGEREIT F: Orcadian rhythms of nocturnal hormones in rheumatoid arthritis: translation from bench to bedside. Ann Rheum Dis 2008; 67: 905-8. (Pubitemid 351956649)
55. TO H, YOSHIMATSU H, TOMONARI M et al.: Methotrexate chronotherapy is effective against rheumatoid arthritis. Chronobiol Int 2011;28:267-74.